Paricalcitol Versus Calcifediol for Treating Hyperparathyroidism in Kidney Transplant Recipients

Paricalcitol Versus Calcifediol for Treating Hyperparathyroidism in Kidney Transplant Recipients

Secondary hyperparathyroidism (SHPT) and vitamin D deficiency are common at kidney transplantation and are associated with some early and late complications. This study was designed to evaluate whether paricalcitol was more effective than nutritional vitamin D for controlling SHPT in de novo kidney...

Full description

Bibliographic Details
Main Authors: Josep M. Cruzado, Ricardo Lauzurica, Julio Pascual, Roberto Marcen, Francesc Moreso, Alex Gutierrez-Dalmau, Amado Andrés, Domingo Hernández, Armando Torres, Maria Isabel Beneyto, Edoardo Melilli, Anna Manonelles, Manuel Arias, Manuel Praga
Format: Article
Language:English
Published: Elsevier 2018-01-01
Series:Kidney International Reports
Subjects:
hyperparathyroidism
kidney transplantation
paricalcitol
vitamin D
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024917303741

Internet

http://www.sciencedirect.com/science/article/pii/S2468024917303741

Similar Items